A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Healthy Adults

Inclusion Criteria: * Healthy adults aged 19-64 years old * Informed consent form has been signed and dated * Able to comply with the requirements of the study Exclusion Criteria: * Known systemic hypersensitive to eggs, chicken proteins, or any of the vaccine components * Personal history of Guillain-Barre syndrome(GBS) * Subjects with severe chronic disease who are considered by investigator to be ineligible for the study * Subjects who received a vaccination within 28 days before enrollment or who are scheduled for another vaccination during the study * Immunocompromised subjects with immunodeficiency disease or subjects receiving immunosuppressive or immunomodulating therapy * Pregnant or lactating women